Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biotech for developing and commercialising the ...

Marea’s Phase IIa study enrolled patients with hypertriglyceridemia—too much fat in the blood. The latest results showed the ...

BioSteel, a Canadian sports hydration and nutrition company, has established a new manufacturing facility in Ontario.

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...

A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T cell therapies for solid tumour cancers.

Precision BioSciences (DTIL) stock saw a 31% premarket surge after positive results from its gene therapy trial for treating ...

McKinley Packaging has officially opened its seventh US facility in Lancaster, Texas, to meet rising demand for sustainable, paper-based packaging.

Organoid intelligence represents a novel intersection of biological sciences and computational technology, utilizing human-derived organoids for advanced ...

New Delhi: Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals.

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis ("UC”) reaches 1,003 of 1,224 ...

A clinical-stage biotechnology company will advance a novel autologous chimeric antigen receptor T-cell therapy that targets ...

At the end of each fiscal year running from October 1 through September 30, the Patent Trial and Appeal Board (“PTAB”) ...